These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 497171)

  • 21. Isolation of a carp complement protein homologous to mammalian factor D.
    Yano T; Nakao M
    Mol Immunol; 1994 Apr; 31(5):337-42. PubMed ID: 8152436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CNBr cleavage of the light chain of human complement factor I and alignment of the fragments.
    Yuan JM; Hsiung LM; Gagnon J
    Biochem J; 1986 Jan; 233(2):339-45. PubMed ID: 2937401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complete amino acid sequence of the catalytic chain of human complement subcomponent C1-r.
    Arlaud GJ; Gagnon J
    Biochemistry; 1983 Apr; 22(8):1758-64. PubMed ID: 6303394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of the peptide bond cleaved during activation of human C1r.
    Arlaud GJ; Gagnon J
    FEBS Lett; 1985 Jan; 180(2):234-8. PubMed ID: 2981722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Change of electrophoretic mobility of purified alternative pathway factor D.
    Konno T; Katsuno Y; Hirai H
    J Immunol Methods; 1978; 21(3-4):325-34. PubMed ID: 670716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of alternative pathway factor D by factor B-related synthetic hexapeptides.
    Lesavre P; Gaillard MH; Halbwachs-Mecarelli L
    Eur J Immunol; 1982 Mar; 12(3):252-4. PubMed ID: 6920299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chemical characterization of cyanogen bromide fragments from the beta-chain of human complement factor C3.
    Lundwall A; Hellman U; Eggertsen G; Sjöquist J
    FEBS Lett; 1984 Apr; 169(1):57-62. PubMed ID: 6714418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Partial sequence of human complement component factor B: novel type of serine protease.
    Christie DL; Gagnon J; Porter RR
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4923-7. PubMed ID: 6776529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clr and Cls subcomponents of human complement: two serine proteinases lacking the 'histidine-loop' disulphide bridge.
    Arlaud GJ; Gagnon J
    Biosci Rep; 1981 Oct; 1(10):779-84. PubMed ID: 6272901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of complement protein D from urine of patients with Fanconi's syndrome.
    Volanakis JE; Macon KJ
    Anal Biochem; 1987 May; 163(1):242-6. PubMed ID: 3650024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Completion of the amino acid sequences of the A and B chains of subcomponent C1q of the first component of human complement.
    Reid KB; Gagnon J; Frampton J
    Biochem J; 1982 Jun; 203(3):559-69. PubMed ID: 6981411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adipsin and complement factor D activity: an immune-related defect in obesity.
    Rosen BS; Cook KS; Yaglom J; Groves DL; Volanakis JE; Damm D; White T; Spiegelman BM
    Science; 1989 Jun; 244(4911):1483-7. PubMed ID: 2734615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and partial characterization of rat factor D.
    Baker BC; Campbell CJ; Grinham CJ; Turcatti G
    Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):775-9. PubMed ID: 1953671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The alternative pathway C3/C5 convertase: chemical basis of factor B activation.
    Lesavre PH; Hugli TE; Esser AF; Müller-Eberhard HJ
    J Immunol; 1979 Aug; 123(2):529-34. PubMed ID: 458145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of erythro-beta-hydroxyasparagine in the EGF-like domain of human C1r.
    Arlaud GJ; Van Dorsselaer A; Bell A; Mancini M; Aude C; Gagnon J
    FEBS Lett; 1987 Sep; 222(1):129-34. PubMed ID: 2820791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and properties of human factor D.
    Volanakis JE; Barnum SR; Kilpatrick JM
    Methods Enzymol; 1993; 223():82-97. PubMed ID: 8271969
    [No Abstract]   [Full Text] [Related]  

  • 37. Complement factor D in uremia.
    Sturfelt G; Truedsson L; Sjöholm A
    N Engl J Med; 1985 Jun; 312(24):1577. PubMed ID: 3846754
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthetic peptide inhibitors of complement serine proteases--I. Identification of functionally equivalent protease inhibitor sequences in serpins and inhibition of C1s and D.
    Glover GI; Schasteen CS; Liu WS; Levine RP
    Mol Immunol; 1988 Dec; 25(12):1261-7. PubMed ID: 3266291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biosynthesis of complement protein D by HepG2 cells: a comparison of D produced by HepG2 cells, U937 cells and blood monocytes.
    Barnum SR; Volanakis JE
    Eur J Immunol; 1985 Nov; 15(11):1148-51. PubMed ID: 2998806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A one-step procedure for preparation of classical pathway (C1q) and alternative pathway (factor D) depleted human serum.
    Praz F; Roque Antunes Barreira MC; Lesavre P
    J Immunol Methods; 1982; 50(2):227-31. PubMed ID: 7045233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.